+612 9045 4394
 
CHECKOUT
Chlamydia Pneumoniae Infection : The Lung and the Heart :  The Lung and the Heart - Luigi Allegra

Chlamydia Pneumoniae Infection : The Lung and the Heart

The Lung and the Heart

Paperback Published: 1999
ISBN: 9788847000476
Number Of Pages: 205

Share This Book:

Paperback

$125.05
or 4 easy payments of $31.26 with Learn more
Ships in 5 to 9 business days

Chlamydia pneumoniae is now recognized as an important human pathogen. Chlamydia pneumoniae is involved in 5%-15% of community acquired pneumonias, and recent data indicate its relevance in severe pneumonia and as a respiratory pathogen in immunocompromised subjects. A causal role for Chlamydia pneumoniae in the initiation, exacerbations and promotion of asthma has been suggested. Approximately 5% of chronic bronchitis exacerbations have been attributed to Chlamydia pneumoniae infections, and chronic infection may facilitate access of other pathogens to the lower respiratory tract. Another field of potential great social impact is the possible involvement of Chlamydia pneumoniae in the pathogenesis of atherosclerosis and related cardiovascular diseases. This book presents the current state-of-the-art knowledge on Chlamydia pneumoniae infection and highlights future lines of research.

History of Chlamydia pneumoniae (TWAR)p. 1
Chlamydia pneumoniae: Culture Methodsp. 9
Serology for Chlamydia pneumoniae (TWAR)p. 16
Chlamydia pneumoniae: Molecular Biology Methodsp. 24
Chlamydia pneumoniae Infections: Applications of Laboratory Methodsp. 33
Chlamydia pneumoniae: How to Document Respiratory Infectionp. 43
Chlamydia pneumoniae: Epidemiologyp. 52
Pharmacological and Pharmacokinetic Basis of Chlamydia pneumoniae Treatmentp. 62
Chlamydia pneumoniae: Clinical Characteristics of Acute Respiratory Infectionsp. 70
Are Atypical Pathogens Important for Patients with Community-Acquired Pneumonia?p. 80
Immunology of Chlamydia pneumoniaep. 88
Chronic Chlamydia pneumoniae Infectionsp. 96
Chlamydia pneumoniae: A New Possible Cause of Asthmap. 114
Chlamydia pneumoniae: An Important Pathogen in Chronic Bronchitisp. 124
Chlamydia pneumoniae: A New Threat for HIV-infected Subjectsp. 134
Chlamydia pneumoniae: Epidemiology of a New Cardiovascular Risk Factorp. 139
Chlamydia pneumoniae and Atherosclerosis: Mechanisms of Vascular Damagep. 152
Chlamydia pneumoniae and Atherosclerosis: Animal Modelsp. 163
Open and Controlled Intervention Trials for "Unusual" Anti-Chlamydia pneumoniae Indications: Asthma, Atherosclerosis, Myocardial Infarctionp. 171
Clarithromycin Treatment of Helicobacter pylori and Chlamydia pneumoniae Infections Decreases Fibrinogen Plasma Level in Patients with Ischemic Heart Diseasep. 173
Antibiotic Treatment in Atherosclerosis and Myocardial Infarctionp. 178
A Controlled Intervention Study with Antibiotics in Symptomatic Coronary Patients Irrespective of Serologyp. 185
Open-Label Before-After Trials of Anti-Chlamydia pneumoniae Antibiotics in Asthmap. 188
Treatment of Chronic Infection with Chlamydia pneumoniae in Asthmap. 191
Chlamydia pneumoniae Infections in Childrenp. 197
Perspectives and Perceptions on the Clinical Relevance of Chlamydia pneumoniae Infectionp. 204
Table of Contents provided by Blackwell. All Rights Reserved.

ISBN: 9788847000476
ISBN-10: 8847000475
Audience: Professional
Format: Paperback
Language: English
Number Of Pages: 205
Published: 1999
Publisher: Springer Verlag
Country of Publication: IT
Dimensions (cm): 23.39 x 15.6  x 1.17
Weight (kg): 0.31